Citi upgraded Fortrea (FTRE) to Buy from Neutral with a price target of $21, up from $12. The firm adjusted ratings in the life science tools and diagnostics group as part of its 2026 outlook. It believes Fortrea is well positioned for margin expansion and upside to consensus estimates.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE: